BioRestorative Therapies submits application for new drug targeting degenerative Dsweweisc disease pain: 4 insightsWritten by Megan Wood | Monday, 09 January 2017 22:16
BioRestorative Therapies submitted an Investigational New Drug Application to the FDA.
Lewisville, Texas-based Orthofix International received FDA approval for its CervicalStim and SpinalStim bone growth stimulators.
Israel-based Expanding Orthopedics reported significant sales growth for its FLXfit expandable cage in the second half of 2016.
Walnut Creek, Calif.-based Providence Medical Technology appointed Gregory S. Curhan the new CFO and senior vice president of corporate development, according to MENAFN.com.
Carlsbad, Calif.-based SeaSpine reported preliminary financial results for the fourth quarter as well as the full year of 2016.
Lyon, France-based Medicrea filed its 510(k) submission to the FDA for its 3-D-printed titanium spinal interbody devices.
The Colorado Medical Society has found physician surveys serve as impactful platforms for advocacy surrounding healthcare concerns, according to the AMA Wire.
Head of Corporate Marketing, Brand and External Communication at NuVasive Michael Farrington discusses the company's direction headed into 2017 after making key acquisitions and platform launches over the past few years.
Johnson & Johnson Medical Device Companies launches orthopedic episode of care platform: 5 things to knowWritten by Laura Dyrda | Monday, 09 January 2017 14:55
Johnson & Johnson Medical Device Companies launched their Orthopaedic Episode of Care Approach, an offering to help health systems and surgeons reduce costs and increase quality for value-based alternative care models in orthopedics.
Cleveland Clinic physician Daniel Neides, MD, penned an op-ed titled "Make 2017 the year to avoid toxins (good luck) and master your domain: Words on Wellness" in which he criticized vaccinations, specifically those given to newborns, according to a News Net 5 report.